Therapeutic potential of spirooxindoles as antiviral agents

Na Ye, Haiying Chen, Eric A. Wold, Pei-Yong Shi, Jia Zhou

Research output: Contribution to journalReview article

125 Citations (Scopus)

Abstract

Antiviral therapeutics with profiles of high potency, low resistance, panserotype, and low toxicity remain challenging, and obtaining such agents continues to be an active area of therapeutic development. Due to their unique three-dimensional structural features, spirooxindoles have been identified as privileged chemotypes for antiviral drug development. Among them, spiro-pyrazolopyridone oxindoles have been recently reported as potent inhibitors of dengue virus NS4B, leading to the discovery of an orally bioavailable preclinical candidate (R)-44 with excellent in vivo efficacy in a dengue viremia mouse model. This review highlights recent advances in the development of biologically active spirooxindoles for their antiviral potential, primarily focusing on the structure-activity relationships (SARs) and modes of action, as well as future directions to achieve more potent analogues toward a viable antiviral therapy.

Original languageEnglish (US)
Pages (from-to)382-392
Number of pages11
JournalACS Infectious Diseases
Volume2
Issue number6
DOIs
StatePublished - Jun 10 2016

Fingerprint

Antiviral Agents
Dengue Virus
Dengue
Viremia
Therapeutics
Structure-Activity Relationship

Keywords

  • antiviral agents
  • DENV
  • HIV
  • influenza virus
  • RSV
  • spirooxindoles

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Therapeutic potential of spirooxindoles as antiviral agents. / Ye, Na; Chen, Haiying; Wold, Eric A.; Shi, Pei-Yong; Zhou, Jia.

In: ACS Infectious Diseases, Vol. 2, No. 6, 10.06.2016, p. 382-392.

Research output: Contribution to journalReview article

Ye, Na ; Chen, Haiying ; Wold, Eric A. ; Shi, Pei-Yong ; Zhou, Jia. / Therapeutic potential of spirooxindoles as antiviral agents. In: ACS Infectious Diseases. 2016 ; Vol. 2, No. 6. pp. 382-392.
@article{05f571b28aca4ea59cfa0b56226388d1,
title = "Therapeutic potential of spirooxindoles as antiviral agents",
abstract = "Antiviral therapeutics with profiles of high potency, low resistance, panserotype, and low toxicity remain challenging, and obtaining such agents continues to be an active area of therapeutic development. Due to their unique three-dimensional structural features, spirooxindoles have been identified as privileged chemotypes for antiviral drug development. Among them, spiro-pyrazolopyridone oxindoles have been recently reported as potent inhibitors of dengue virus NS4B, leading to the discovery of an orally bioavailable preclinical candidate (R)-44 with excellent in vivo efficacy in a dengue viremia mouse model. This review highlights recent advances in the development of biologically active spirooxindoles for their antiviral potential, primarily focusing on the structure-activity relationships (SARs) and modes of action, as well as future directions to achieve more potent analogues toward a viable antiviral therapy.",
keywords = "antiviral agents, DENV, HIV, influenza virus, RSV, spirooxindoles",
author = "Na Ye and Haiying Chen and Wold, {Eric A.} and Pei-Yong Shi and Jia Zhou",
year = "2016",
month = "6",
day = "10",
doi = "10.1021/acsinfecdis.6b00041",
language = "English (US)",
volume = "2",
pages = "382--392",
journal = "ACS Infectious Diseases",
issn = "2373-8227",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Therapeutic potential of spirooxindoles as antiviral agents

AU - Ye, Na

AU - Chen, Haiying

AU - Wold, Eric A.

AU - Shi, Pei-Yong

AU - Zhou, Jia

PY - 2016/6/10

Y1 - 2016/6/10

N2 - Antiviral therapeutics with profiles of high potency, low resistance, panserotype, and low toxicity remain challenging, and obtaining such agents continues to be an active area of therapeutic development. Due to their unique three-dimensional structural features, spirooxindoles have been identified as privileged chemotypes for antiviral drug development. Among them, spiro-pyrazolopyridone oxindoles have been recently reported as potent inhibitors of dengue virus NS4B, leading to the discovery of an orally bioavailable preclinical candidate (R)-44 with excellent in vivo efficacy in a dengue viremia mouse model. This review highlights recent advances in the development of biologically active spirooxindoles for their antiviral potential, primarily focusing on the structure-activity relationships (SARs) and modes of action, as well as future directions to achieve more potent analogues toward a viable antiviral therapy.

AB - Antiviral therapeutics with profiles of high potency, low resistance, panserotype, and low toxicity remain challenging, and obtaining such agents continues to be an active area of therapeutic development. Due to their unique three-dimensional structural features, spirooxindoles have been identified as privileged chemotypes for antiviral drug development. Among them, spiro-pyrazolopyridone oxindoles have been recently reported as potent inhibitors of dengue virus NS4B, leading to the discovery of an orally bioavailable preclinical candidate (R)-44 with excellent in vivo efficacy in a dengue viremia mouse model. This review highlights recent advances in the development of biologically active spirooxindoles for their antiviral potential, primarily focusing on the structure-activity relationships (SARs) and modes of action, as well as future directions to achieve more potent analogues toward a viable antiviral therapy.

KW - antiviral agents

KW - DENV

KW - HIV

KW - influenza virus

KW - RSV

KW - spirooxindoles

UR - http://www.scopus.com/inward/record.url?scp=85006208818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006208818&partnerID=8YFLogxK

U2 - 10.1021/acsinfecdis.6b00041

DO - 10.1021/acsinfecdis.6b00041

M3 - Review article

C2 - 27627626

AN - SCOPUS:85006208818

VL - 2

SP - 382

EP - 392

JO - ACS Infectious Diseases

JF - ACS Infectious Diseases

SN - 2373-8227

IS - 6

ER -